gsk
-
Advertisers
Healthcare is right direction for Unilever but GSK bid may have come too late
Investors seem none too impressed by Unilever’s series of £50bn bids for GSK’s healthcare businesses, the shares (already under pressure)…
Read More » -
Advertisers
Another media win for Publicis as it lands $1.8bn GSK
Publicis boss Arthur Sadoun and Publicis Media head Steve King have landed another big name – pharma giant GSK’s $1.8bn…
Read More » -
Advertisers
WPP’s MediaCom in spotlight as GSK reviews, Revlon leaves
WPP’s giant MediaCom agency has bounced back strongly from losing £2bn VW to Omnicom’s PHD a couple of years ago…
Read More » -
Advertisers
Havas lures Slough from OgilvyOne to head new GSK deal
Havas has poached OgilvyOne global managing partner Chris Slough to head its GSK digital and content business. Slough (below) previously…
Read More » -
Advertisers
WPP looks like biggest winner in GSK agency review
GlaxoSmithKline Consumer Healthcare has completed the agency review it launched following the establishment of a joint venture with Novartis. The…
Read More » -
Advertisers
GSK media goes to MediaCom and PHD – so what’s new?
The great media agency wars elude us all – $20-30bn up for review it seems – but it does get…
Read More » -
Advertisers
Now drugs giant GSK joins the agency rebate gang
Giant drugs company GSK, some of whose employees in China have been detained by the authorities for allegedly bribing doctors…
Read More »